A common plasma lipidomics signature of cardiometabolic and coronary risk in statin users

Autor: S Rocchiccioli, N Di Giorgi, E Michelucci, G Signore, AJHA Scholte, J Knuuti, RR Buechel, A Teresinska, MN Pizzi, A Roque, R Poddighe, O Parodi, G Pelosi, D Neglia, C Caselli

Publikováno v: Cardiovascular Research. 118

Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Commission in the H2020 program: Project SMARTool, “Simulation Modeling of coronary ARTery disease: a tool for clinical decision supp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fede66400985838dc0b4dcf7a141d478
https://doi.org/10.1093/cvr/cvac066.091

Infection vs inflammation in prosthetic heart valves by [ ¹⁸ F]FDG-PET/CT: A practical tutorial for accurate interpretation.

Autor: Roque A; Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Nuclear Cardiology Unit, Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain; IDI (Institut de Diagnòstic per la Imatge), Spain; Universitat Autònoma de Barcelona, Spain. Electronic address: albert_roque@hotmail.com., Pizzi MN; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Nuclear Cardiology Unit, Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Universitat Autònoma de Barcelona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2024 Oct 05, pp. 102053. Date of Electronic Publication: 2024 Oct 05.

Plasma lipidomics and coronary plaque changes: a substudy of the SMARTool clinical trial.

Autor: Smit JM; Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Rocchiccioli S; Institute of Clinical Physiology CNR, Viale Giuseppe Moruzzi 1, 56124 Pisa, Italy., Signore G; Department of Biology, Biochemistry Unit, University of Pisa, Pisa, Italy., Michelucci E; Institute of Clinical Physiology CNR, Viale Giuseppe Moruzzi 1, 56124 Pisa, Italy., Di Giorgi N; Institute of Clinical Physiology CNR, Viale Giuseppe Moruzzi 1, 56124 Pisa, Italy., van Rosendael AR; Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., El Mahdiui M; Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Neglia D; Cardiovascular and Imaging Departments, Fondazione Toscana Gabriele Monasterio, Pisa, Italy., Knuuti J; Heart Center and PET Centre, Turku University Hospital and University of Turku, Turku, Finland., Saraste A; Heart Center and PET Centre, Turku University Hospital and University of Turku, Turku, Finland., Buechel RR; Department of Nuclear Medicine, Cardiac Imaging, University Hospital and University of Zurich, Zurich, Switzerland., Teresinska A; Department of Nuclear Medicine, National Institute of Cardiology, Warsaw, Poland., Pizzi MN; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Roque A; Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Poddighe R; Cardiologia, ASL12 U.O.C., Viareggio, Italy., Mertens BJ; Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands., Caselli C; Institute of Clinical Physiology CNR, Viale Giuseppe Moruzzi 1, 56124 Pisa, Italy., Parodi O; Cardiovascular Department, Fondazione Toscana G. Monasterio, Pisa, Italy., Pelosi G; Institute of Clinical Physiology CNR, Viale Giuseppe Moruzzi 1, 56124 Pisa, Italy., Scholte AJ; Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Publikováno v: European heart journal. Cardiovascular Imaging [Eur Heart J Cardiovasc Imaging] 2024 Jul 31; Vol. 25 (8), pp. 1089-1098.

Nuclear imaging in the new ESC Guidelines: the age of maturity.

Autor: Erba PA; Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy. paolaanna.erba@unimib.it.; Nuclear Medicine Unit, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy. paolaanna.erba@unimib.it.; Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, Groningen, The Netherlands. paolaanna.erba@unimib.it., Pizzi MN; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Roque A; Department of Radiology, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Slart RHJA; Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, Groningen, The Netherlands.; Biomedical Photonic Imaging Group, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Mar; Vol. 51 (4), pp. 938-941.

A protection against infection but a risk of misdiagnosis? False positive uptake in an implanted cardiac device.

Autor: Roque A; Department of Radiology, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. albert_roque@hotmail.com.; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain. albert_roque@hotmail.com.; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. albert_roque@hotmail.com.; Universitat Autònoma de Barcelona, Barcelona, Spain. albert_roque@hotmail.com., Francisco-Pascual J; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Andrés-Cordón JF; Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Fernández-Hidalgo N; Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Herance JR; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Cuellar-Calabria H; Department of Radiology, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Aguadé-Bruix S; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Pizzi MN; Department of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2023 Dec; Vol. 30 (6), pp. 2846-2849. Date of Electronic Publication: 2023 Jul 05.